SCHEMBL3308145

SCHEMBL3308145

CO[Si](CCCC(C)=O)(OC)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
PAOX Q6QHF9 4/20 0.39
ACHE P22303 1/20 0.39
LMNA P02545 3/20 0.35
SLC15A2 Q16348 1/20 0.35
TSHR P16473 2/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
RECQL P46063 1/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPT P10636 1/20 0.31
MAOA P21397 1/20 0.31
SLC6A2 P23975 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5695229 0.93 PAOX (0.43) ALDH1A1PAOXACHELMNASLC15A2
SCHEMBL11049399 0.85 ALDH1A1 (0.45) ALDH1A1PAOXACHELMNASLC15A2
SCHEMBL15397831 0.83 KDM4E (0.43) LMNATSHRMGAMGAASI
SCHEMBL27516755 0.81 LMNA (0.35) LMNATSHRRECQLKDM4ETP53
SCHEMBL700717 0.81 TSHR (0.48) ALDH1A1LMNATSHR
SCHEMBL6244850 0.80 LMNA (0.38) LMNA
SCHEMBL14594300 0.80 PAOX (0.42) ALDH1A1PAOXACHELMNATSHR
SCHEMBL6228812 0.79 TSHR (0.61) ALDH1A1LMNATSHRMGAMGAA
SCHEMBL8578426 0.79 LMNA (0.34) LMNATSHRRECQL
SCHEMBL13304774 0.79 ALDH1A1 (0.39) ALDH1A1PAOXACHELMNASLC15A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461368-B2 Process for preparing organic silane compounds having beta-cyano ester group LG CHEM, LTD. (KR) 2013-06-11 US disclosed
EP-2099809-B1 PROCESS FOR PREPARING ORGANIC SILANE COMPOUNDS HAVING BETA-CYANO ESTER GROUP LG CHEMICAL LTD (KR) 2013-03-06 EP disclosed
US-20100113812-A1 PROCESS FOR PREPARING ORGANIC SILANE COMPOUNDS HAVING BETA-CYANO ESTER GROUP LG CHEM, LTD. (KR) 2010-05-06 US disclosed
EP-2099809-A1 PROCESS FOR PREPARING ORGANIC SILANE COMPOUNDS HAVING BETA-CYANO ESTER GROUP LG Chem, Ltd. (KR) 2009-09-16 EP disclosed
WO-2008069515-A1 PROCESS FOR PREPARING ORGANIC SILANE COMPOUNDS HAVING BETA-CYANO ESTER GROUP LG CHEM, LTD. (KR) 2008-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113812-A1 PROCESS FOR PREPARING ORGANIC SILANE COMPOUNDS HAVING BETA-CYANO ESTER GROUP PCCA, IDH1, DHPS ALDH1A1 596/4885PAOX 1578/4885ACHE 1869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.